The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Acetyl-L-carnitine arginyl amide (ST857) increases calcium channel density in rat pheochromocytoma (PC12) cells.
K Tewari; J M Simard; Y B Peng; K Werrbach-Perez; J R Perez-Polo (Profiled Author: J Marc Simard)
Division of Neurological Surgery, University of Maryland Medical System, Baltimore, USA.
Journal of neuroscience research 1995;40(3):371-8.
We used the patch clamp technique to study the effect of acetyl-L-carnitine arginyl amide (ALCAA) and of nerve growth factor (NGF) on availability of L-type Ca2+ channels in rat pheochromocytoma (PC12) cells maintained in defined medium. Channel availability was measured as number of channels in the patch x the probability of opening (n.Po). In patches from control cells, cells exposed to NGF (10 ng/ml) for six days, and cells exposed to ALCAA (1 mM) for six days, n.Po, measured during 200-240 ms pulses to -10 mV (holding potential, -60 mV), was 0.102 +/- 0.089 (5 cells), 0.173 +/- 0.083 (5 cells), and 0.443 +/- 0.261 (7 cells), respectively. The 4.3-fold increase for the ALCAA-treated cells was significantly different from control (P < 0.05), whereas that for the NGF-treated cells was not. For the same conditions, the maximum number of superimposed openings at -10 mV was 1.3 +/- 0.5 (6 cells), 1.6 +/- 0.5 (8 cells), and 3.3 +/- 1.8 (8 cells), with the value for the ALCAA-treated cells being significantly different from control (P < 0.001). Additional analysis showed that the distribution of channel open times, the time constants, and the voltage dependence of activation were not changed by prolonged exposure to ALCAA. Short-term exposure to both ALCAA as well as to the parent compound, acetyl-L-carnitine (ALCAR), did not cause an increase but rather a decrease in n.Po, and this short-term effect of both compounds was blocked by neomycin, an inhibitor of phospholipase C.(ABSTRACT TRUNCATED AT 250 WORDS)
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
J M Simard; K Tewari; A Kaul; B Nowicki; L S Chin; S K Singh; J R Perez-PoloJournal of neuroscience research 1996;45(3):216-25.
K N Westlund; Y Lu; K Werrbach-Perez; C E Hulsebosch; B Morgan; D P Pizzo; H M Eisenberg; J R Perez-PoloInternational journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 1992;10(5):361-73.
Ke Ren; Viviana Puig; Roger L Papke; Yoshihito Itoh; Jeffrey A Hughes; Edwin M MeyerJournal of neurochemistry 2005;94(4):926-33.
Appears in this Publication
Author of this Publication